By G HossainPosted on September 22, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Novo CEO Maziar Mike Doustdar disclosed an additional 4,000 staff departures, which a spokesperson told BioSpace are linked to attrition and other measures. Novo’s workforce reduction climbs to 13,000 to fuel R&D work Post navigation Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics2026 IPO blitz continues with 4 new biotech filings
